| 1 | [SID49823412] | Active | IC50 | 3.19 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | IC50 | 3.19 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 2 | [SID49823412] | Active | IC50 | 3.19 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | IC50 | 3.19 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 3 | [SID49823412] | Active | IC50 | 3.19 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | IC50 | 3.19 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 4 | [SID49823412] | Active | IC50 | 9.42 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | IC50 | 9.42 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 5 | [SID49823412] | Active | IC50 | 9.42 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | IC50 | 9.42 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 6 | [SID49823412] | Active | IC50 | 9.42 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | IC50 | 9.42 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 7 | [SID49823412] | Active | Potency | 10 | Confirmation Assay for Identification of Novel General Anesthetics [AID489008, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Confirmation Assay for Identification of Novel General Anesthetics | | AID | 489008 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 8 | [SID49823412] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID492953, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 492953 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 9 | [SID49823412] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID493034, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 493034 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 10 | [SID49823412] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 11 | [SID49823412] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 12 | [SID49823412] | Active | | | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID602472, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 602472 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 13 | [SID49823412] | Active | | | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID602472, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 602472 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 14 | [SID49823412] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_2, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 15 | [SID49823412] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_2, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 16 | [SID49823412] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_3, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 17 | [SID49823412] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_3, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 18 | [SID49823412] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 19 | [SID49823412] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 20 | [SID49823412] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_5, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 21 | [SID49823412] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_5, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 22 | [SID49823412] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_6, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 23 | [SID49823412] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_6, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 24 | [SID49823412] | Inactive | IC50 | 42.7 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | IC50 | 42.7 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 25 | [SID49823412] | Inactive | IC50 | 42.7 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | IC50 | 42.7 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 26 | [SID49823412] | Inactive | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_1, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 27 | [SID49823412] | Inactive | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_1, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 28 | [SID49823412] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID504803, Type: screening] | HTRA1 protein [gi:121945198] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 504803 | | BioAssay type | screening | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 29 | [SID49823412] | Inactive | Potency | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 30 | [SID49823412] | Inactive | | | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) [AID1845, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) | | AID | 1845 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 31 | [SID49823412] | Inactive | | | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) [AID1800, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) | | AID | 1800 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 32 | [SID49823412] | Inactive | | | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity [AID652162, Type: screening] | Toxin B [Clostridium difficile 630] [gi:126698238] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652162 | | BioAssay type | screening | | Target | Toxin B [Clostridium difficile 630] [gi:126698238] | | PubMed | | | Data Table |  |
|
| 33 | [SID49823412] | Inactive | | | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay [AID602438, Type: screening] | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay | | AID | 602438 | | BioAssay type | screening | | Target | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] | | PubMed | | | Data Table |  |
|
| 34 | [SID49823412] | Inactive | Potency | | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 35 | [SID49823412] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set [AID588497, Type: Literature] | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | | AID | 588497 | | BioAssay type | Literature | | Target | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] | | PubMed | 16604538 | | Data Table |  |
|
| 36 | [SID49823412] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table |  |
|
| 37 | [SID49823412] | Inactive | Potency | | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 38 | [SID49823412] | Inactive | Potency | | qHTS Assay for Inhibitors of Influenza NS1 Protein Function [AID2326, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Influenza NS1 Protein Function | | AID | 2326 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] | | PubMed | | | Data Table |  |
|
| 39 | [SID49823412] | Inactive | IC50 | | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition [AID588689, Type: confirmatory] | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition | | AID | 588689 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] | | PubMed | | | Data Table |  |
|
| 40 | [SID49823412] | Inactive | IC50 | | Discovery of Small Molecule Probes for H1N1 Influenza NS1A [AID504329, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Discovery of Small Molecule Probes for H1N1 Influenza NS1A | | AID | 504329 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] | | PubMed | | | Data Table |  |
|
| 41 | [SID49823412] | Inactive | Potency | | qHTS Assay for NPC1 Promoter Activators [AID485313, Type: confirmatory] | NPC1 gene product [Homo sapiens] [gi:255652944] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for NPC1 Promoter Activators | | AID | 485313 | | BioAssay type | confirmatory | | Target | NPC1 gene product [Homo sapiens] [gi:255652944] | | PubMed | | | Data Table |  |
|
| 42 | [SID49823412] | Inactive | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 43 | [SID49823412] | Inactive | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 44 | [SID49823412] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504357, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504357 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 45 | [SID49823412] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504357, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504357 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 46 | [SID49823412] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 47 | [SID49823412] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 48 | [SID49823412] | Inactive | EC50 | | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1777, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1777 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 49 | [SID49823412] | Inactive | EC50 | | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1777, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1777 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 50 | [SID49823412] | Inactive | EC50 | | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1777, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49823412 | | CID | 2970781 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1777 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|